Release Date: 11/12/14 17:49 Summary: Change in substantial holding from PPT Price Sensitive: No Download Document 131.34KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%